Skip to main content

ATMP Engage PPI Directory

The PPI Directory contains patient and public involvement (PPI) resources for developers of cell and gene therapies, including toolkits, guidelines, advice, templates and case studies.

PPI Directory

PPI Themes
Research Field
Organisation Type
Development Stage
Audience
Country
Content Type
  • Knowledge Building
  • Standards for PPI
Showing 5 of 83 results.
Page 8 of 17
2020

EMA Regulatory Science to 2025 - strategic reflection

Report reflecting on the EMA's regulatory framework by the European Medicines Agency

Research Field

  • Other

Organisation Type

  • Regulatory Body

Development Stage

  • Regulatory Approval

Audience

  • Researchers/Developers
  • Public/Patients

Country

  • Europe

Content Type

  • Resource

Advanced Therapy Classification

Classification of ATMPs by the European Medicines Agency

Research Field

  • ATMP/Gene Therapy Development

Organisation Type

  • Regulatory Body

Audience

  • Researchers/Developers
  • Public/Patients
  • Charity Sector
  • Industry
  • Other groups

Country

  • Europe

Content Type

  • Resource
2018

Guideline on safety and efficacy follow up and risk management of ATMPs

Report on guidance on long term follow up for ATMPs by the European Medicines Agency

Research Field

  • ATMP/Gene Therapy Development

Organisation Type

  • Regulatory Body

Development Stage

  • Regulatory Approval

Audience

  • Researchers/Developers

Country

  • Europe

Content Type

  • Resource
2018

Procedural advice on the evaluation of advanced therapy medicinal product in accordance with Article 8 of Regulation (EC) No 1394/2007

Document outlining the procedure on ATMP evaluation by European Medicines Agency

Research Field

  • ATMP/Gene Therapy Development

Organisation Type

  • Regulatory Body

Development Stage

  • Regulatory Approval

Audience

  • Researchers/Developers

Country

  • Europe

Content Type

  • Resource
2019

Patients' and consumers' working party

Patient' and Consumers' Working Party meeting notes and objectives published by the European Medicines Agency (EMA)

Research Field

  • Other

Organisation Type

  • Regulatory Body

Development Stage

  • Regulatory Approval

Audience

  • Researchers/Developers
  • Public/Patients
  • Charity Sector
  • Industry
  • Other groups

Country

  • Europe

Content Type

  • Resource